{
  "trial_id": "NCT00275938",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Adult male or female, 18 to 60 years of age chronic hepatitis B patients Patient must have documented positive serum HBsAg for a minimum of 6 months prior to entry into study.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "have documented positive serum HBsAg for a minimum of 6 months prior to entry into study.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients must show evidence of HBV replication and hepatitis documented by Positive serum HBV-DNA within 3 months prior to entry (HBV-DNA > 2.5 pg/ml) Positive serum HBeAg within 3 months prior to entry.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Documented presence of abnormal alanine aminotransferase (ALT) twice within 3 months prior to entry (2 to 10 fold above the upper normal level)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Liver biopsy finding shows chronic hepatitis without liver cirrhosis",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Compensated liver disease with the following minimum hematological and serum biochemical criteria:",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Hemoglobin values of \u2265 12 gm/dL for both sexes",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "WBC \u2265 3,000/mm3",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Neutrophil count \u2265 1,500/ mm3",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Platelets \u2265 100,000/ mm3",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Total bilirubin \u2264 2 mg/dL",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Albumin \u2265 3.5 g/dL",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients older than 60 years of age",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Any cause for the liver disease based on patient history or biopsy (where applicable) other than chronic hepatitis B, including but not limited to:",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Co-infection with HCV and/or HIV",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Hemochromatosis (iron despistion > 2 + in liver parenchyma)",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient is a 53-year-old man with chronic HCV infection. He has been on IFN and RBV combination therapy for the past 9 months, but direct antiviral drugs were added to his treatment 6 months ago. His medical record shows previous positive HCV RNA tests as well as positive enzyme immunoassay for anti-HCV-antibodies.",
  "_meta": {
    "topic_id": "27",
    "trial_id": "NCT00275938",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}